THE LONG-TERM OUTCOME OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AND NEGATIVE INTERIM PET FAILING ABVD MIGHT BE WORSE THAN THAT OF INTERIM PET POSITIVE PATIENTS UNDERGOING EARLY TREATMENT INTENSIFICATION WITH ESCALATED BEACOPP

被引:0
|
作者
Zaucha, J. M. [1 ,2 ]
Malkowski, B. [3 ]
Subocz, E. [4 ]
Tajer, J. [5 ]
Kulikowski, W. [6 ]
Panebianco, M. [7 ]
Grad, J. [8 ]
Rybka, J. [9 ]
Kroll-Balcerzak, R. [10 ]
Romanowicz, A. [11 ]
Chamier-Cieminska, A. [12 ]
Kurczab, P. [13 ,14 ]
Cimino, G. [7 ]
Chauvie, S. [15 ]
Knopinska-Posluszny, W. [6 ]
Walewski, J. [5 ]
Gallamini, A. [16 ]
机构
[1] Gdynia Oncol Ctr, Gdynia, Poland
[2] Med Univ Gdansk, Dept Oncol Propedeut, Gdansk, Poland
[3] Oncol Ctr, Dept Nucl Med, Bydgoszcz, Poland
[4] Mil Inst Med, Dept Hematol, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Inst Oncol, Dept Lymphoproliferat Dis, Warsaw, Poland
[6] Warmia & Mazury Med Univ, Interior Minist Hosp, Clin Dept Hematol, Olsztyn, Poland
[7] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[8] Reg Hosp, Hematol Unit, Opole, Poland
[9] Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Wroclaw, Poland
[10] Univ Med Sch, Dept Hematol, Poznan, Poland
[11] Cent Clin Hosp MSW, Dept Hematol, Warsaw, Poland
[12] Oncol Ctr, Dept Clin Oncol, Bydgoszcz, Poland
[13] Med Ctr Mrukmed, Outpatient Chemotherapy Unit, Rzeszow, Poland
[14] Subcarpathian Oncol Ctr, Dept Clin Oncol, Brzozow, Poland
[15] Santa Croce & Carle Hosp, Med Phys Dept, Cuneo, Italy
[16] Univ Nice, Lacassagne Canc Ctr, Res Innovat & Stat Dept, Nice, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P100
引用
收藏
页码:53 / 54
页数:2
相关论文
共 49 条
  • [1] Early treatment intensification with escalated BEACOPP after interim PET in advanced Hodgkin Lymphoma patients not responding to ABVD therapy
    Malkowski, B.
    Danielewicz, I.
    Lesniewski-Kmak, K.
    Zalewska, M.
    Zaucha, R.
    Szefer, J.
    Zaucha, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S476 - S476
  • [2] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [3] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE, ADVANCED-STAGE, ABVD-TREATED HODGKIN LYMPHOMA PATIENTS
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Stelitano, C.
    Feldman, T.
    Gavarotti, P.
    Sorasio, R.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S22 - S22
  • [4] Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD
    Fiore, F.
    Patti, K.
    Viviani, S.
    Rossi, A.
    Di Raimondo, F.
    Cantonetti, M.
    Feldman, T.
    Biggi, A.
    Barrington, S.
    Gallamini, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2016, 33 (01) : 1 - 4
  • [6] EARLY CHEMOTHERAPY INTENSIFICATION WITH ESCALATED BEACOPP IN ADVANCED-STAGE HODGKIN LYMPHOMA WITH A POSITIVE INTERIM PET-CT AFTER 2 ABVD CYCLES: LONG-TERM RESULTS OF THE GITIL/FIL HD 0607 TRIAL
    Gallamini, A.
    Rossi, A.
    Patti, K.
    Picardi, M.
    Romano, A.
    Cantonetti, M.
    La Nasa, G.
    Trentin, L.
    Bolis, S.
    Rapezzi, D.
    Viviani, S.
    Gianni, A. M.
    Zoli, V.
    Gottardi, D.
    Tarella, C.
    Gavarotti, P.
    Corradini, P.
    Cimminiello, M.
    Schiavotto, C.
    Parvis, G.
    Zanotti, R.
    Gini, G.
    Ferreri, A. J.
    Viero, P.
    Miglino, M.
    Billio, A.
    Avigdor, A.
    Prosperini, G.
    Bergesio, F.
    Pavoni, C.
    Rambaldi, A.
    HAEMATOLOGICA, 2017, 102 : 145 - 146
  • [7] EARLY CHEMOTHERAPY INTENSIFICATION WITH BEACOPP IN HIGH-RISK, INTERIM-PET POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA, IMPROVES THE OVERALL TREATMENT OUTCOME OF ABVD: A GITIL MULTICENTER CLINICAL STUDY
    Gallamini, A.
    Fiore, F.
    Sorasio, R.
    Rambaldi, A.
    Patti, C.
    Stelitano, C.
    Viviani, S.
    Di Raimondo, F.
    Feldman, T.
    Biggi, A.
    Rossi, A.
    Mistretta, A.
    Bonfante, V.
    Chiarenza, A.
    Cantonetti, M.
    Gavarotti, P.
    Tarella, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 204 - 204
  • [8] Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
    Gallamini, Andrea
    Tarella, Corrado
    Viviani, Simonetta
    Rossi, Andrea
    Patti, Caterina
    Mule, Antonino
    Picardi, Marco
    Romano, Alessandra
    Cantonetti, Maria
    La Nasa, Giorgio
    Trentin, Livio
    Bolis, Silvia
    Rapezzi, Davide
    Battistini, Roberta
    Gottardi, Daniela
    Gavarotti, Paolo
    Corradini, Paolo
    Cimminiello, Michele
    Schiavotto, Corrado
    Parvis, Guido
    Zanotti, Roberta
    Gini, Guido
    Ferreri, Andres J. M.
    Viero, Piera
    Miglino, Maurizio
    Billio, Atto
    Avigdor, Abraham
    Biggi, Alberto
    Fallanca, Federico
    Ficola, Umberto
    Gregianin, Michele
    Chiaravalloti, Agostino
    Prosperini, Giuseppe
    Bergesio, Fabrizio
    Chauvie, Stephane
    Pavoni, Chiara
    Gianni, Alessandro Massimo
    Rambaldi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 454 - +
  • [9] Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 758 - 760
  • [10] Early detection of chemotherapy resistance in negative interim FDG-PET Hodgkin lymphoma patients
    Cerci, Juliano
    Zanoni, Lucia
    Shah, Chirayu
    Chiti, Arturo
    Lee, Sze Ting
    Meneghetti, Jose
    Hutchings, Martin
    Biggi, Alberto
    Delbeke, Dominique
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53